SAN FRANCISCO, Nov. 27, 2025 /PRNewswire/ -- The global lateral flow assays market size is expected to reach USD 17.44 billion by 2033, registering a CAGR of 6.98% from 2025 to 2033, according to a ...

Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. As the coronavirus pandemic continues ...

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Components Market by Type, Application, Technique, End User, and Region - Global Forecast to 2030" has been added to ...

Lateral Flow Assays Market, By Product Type (Kits & Reagents and Lateral Flow Readers), By Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), By Application (Clinical ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

Due to unforeseen circumstances, Klaus Hochleitner is unable to host this webinar as originally planned. Thanks to Dominik de Cassan for covering the session. Quantitative tests require a much more ...

In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics. Before the COVID-19 pandemic, the pregnancy test was the ...

CHICAGO, Nov. 17, 2020 /PRNewswire/ -- According to the new market research report "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 14, 2025 /PRNewswire/ -- The global Lateral Flow Assays Market, valued at US$7.93 billion in ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...